RecruitingNot ApplicableNCT06811883

Optimising Hip Mobility, Hamstring Flexibility and Performance Using Lightback

Optimising Hip Mobility, Hamstring Flexibility and Performance in Elite Sprint and Hurdles Athletes Using Lightback: an Experimental Pilot Study


Sponsor

Universidad Católica de Ávila

Enrollment

20 participants

Start Date

Jan 31, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In athletics, in the sprint and hurdles disciplines, muscle injuries account for a significant proportion of injuries. The hamstrings are particularly vulnerable, accounting for between 12% and 26% of all injuries in these sports. A single-blind study was conducted on 20 hurdler patients with the intention of assessing hip mobility, hamstring flexibility and performance. To collect this data, the research team will conduct examinations and interviews with the athletes in two groups: an experimental group using LightBack and a placebo group.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Sprinters and hurdlers aged 18 to 30 years.
  • No history of recent (less than 6 months) hamstring or hip injury.
  • Signed informed consent.

Exclusion Criteria9

  • Cruciate or hamstring tears less than 6 months old;
  • Hip and back surgery less than 3 months old;
  • Chronic or acute back problems;
  • Pregnancy;
  • Osteoporosis
  • Tumours, bone cancer of the hip and pelvis;
  • Direct trauma to the back of the thigh less than 6 months old.
  • Orthopaedic or neurological pathologies affecting mobility or muscle activation.
  • Participation in another specific training protocol

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELIGHTBACK

This group will perform a standard 20-minute warm-up, and the LIGHTBACK protocol is also included.

DEVICEPlacebo

This group will perform a standard 20-minute warm-up, but the LIGHTBACK protocol is not included and a similar placebo is used.


Locations(1)

Universidad Pontificia de Salamanca

Salamanca, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06811883